{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:04:15Z","timestamp":1762974255205,"version":"3.45.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jaccao.2021.09.008","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T15:32:10Z","timestamp":1640100730000},"page":"650-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Potential Applications for Targeted Gene\u00a0Therapy to Protect Against Anthracycline Cardiotoxicity"],"prefix":"10.1016","volume":"3","author":[{"given":"Cindy Y.","family":"Kok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jett C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leszek","family":"Lisowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy","family":"Kizana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jaccao.2021.09.008_bib1","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jaccao.2021.09.008_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A\u00a0clinicopathologic analysis of adriamycin cardiotoxicity","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jaccao.2021.09.008_bib3","article-title":"Cardiotoxic effect of modern anthracycline dosing on left ventricular ejection fraction: a systematic review and metaanalysis of placebo arms from randomized controlled trials","volume":"10","author":"Jeyaprakash","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib4","first-page":"62","article-title":"Refining the 10-year prediction of left ventricular systolic dysfunction in long-term survivors of childhood cancer","volume":"3","author":"Leerink","year":"2021","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"issue":"8","key":"10.1016\/j.jaccao.2021.09.008_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.jaccao.2021.09.008_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1200\/JCO.2005.02.3879","article-title":"Dexrazoxane-associated risk for acute myeloid leukemia\/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease","volume":"25","author":"Tebbi","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.jaccao.2021.09.008_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/leu.2009.261","article-title":"Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group","volume":"24","author":"Salzer","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib8","first-page":"54","article-title":"Efficacy of neurohormonal therapies in preventing cardiotoxicity in patients with cancer undergoing chemotherapy","volume":"1","author":"Vaduganathan","year":"2019","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"issue":"9","key":"10.1016\/j.jaccao.2021.09.008_bib9","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1073\/pnas.82.9.2985","article-title":"O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea","volume":"82","author":"Brent","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jaccao.2021.09.008_bib10","first-page":"613","article-title":"O6-methylguanine-DNA methyltransferase in pediatric primary brain tumors: relation to patient and tumor characteristics","volume":"7","author":"Bobola","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.jaccao.2021.09.008_bib11","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2002.06.110","article-title":"Clinical relevance of MGMT in the treatment of cancer","volume":"20","author":"Gerson","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.jaccao.2021.09.008_bib12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood.V88.5.1649.1649","article-title":"Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU","volume":"88","author":"Gerson","year":"1996","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jaccao.2021.09.008_bib13","first-page":"1936","article-title":"Isolation of human-alkylguanine-DNA alkyltransferase mutants highly resistant to inactivation by -benzylguanine","volume":"58","author":"Xu-Welliver","year":"1998","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/j.jaccao.2021.09.008_bib14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jgm.937","article-title":"Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow","volume":"8","author":"Kramer","year":"2006","journal-title":"J\u00a0Gene Med"},{"issue":"9","key":"10.1016\/j.jaccao.2021.09.008_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cgt.7700490","article-title":"Hematoprotection and enrichment of transduced cells in\u00a0vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells","volume":"9","author":"Jansen","year":"2002","journal-title":"Cancer Gene Ther"},{"issue":"13","key":"10.1016\/j.jaccao.2021.09.008_bib16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2010.34.3467","article-title":"Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children","volume":"30","author":"Visscher","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.jaccao.2021.09.008_bib17","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","article-title":"NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity","volume":"112","author":"Wojnowski","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jaccao.2021.09.008_bib18","first-page":"539","article-title":"Genetics of anthracycline cardiomyopathy in cancer survivors","volume":"2","author":"Bhatia","year":"2020","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"issue":"8","key":"10.1016\/j.jaccao.2021.09.008_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/10430349950017950","article-title":"Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain\/human multiple drug resistance 1 fusion gene","volume":"10","author":"Dell'Acqua","year":"1999","journal-title":"Human Gene Therapy"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol Ther"},{"issue":"10024","key":"10.1016\/j.jaccao.2021.09.008_bib21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jaccao.2021.09.008_bib22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCIMAGING.112.000320","article-title":"Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling","volume":"6","author":"Konkalmatt","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7366","key":"10.1016\/j.jaccao.2021.09.008_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature10407","article-title":"SUMO1-dependent modulation of SERCA2a in heart failure","volume":"477","author":"Kho","year":"2011","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jaccao.2021.09.008_bib24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"10097","key":"10.1016\/j.jaccao.2021.09.008_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2021.09.008_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pediatrneurol.2019.05.005","article-title":"Impact of age and motor function in a phase 1\/2A study of infants with SMA type 1 receiving single-dose gene replacement therapy","volume":"98","author":"Lowes","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"11","key":"10.1016\/j.jaccao.2021.09.008_bib27","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.hlc.2018.08.014","article-title":"Directed evolution of adeno-associated virus vectors in human cardiomyocytes for cardiac gene therapy","volume":"27","author":"Kok","year":"2018","journal-title":"Heart, Lung and Circulation"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","article-title":"AAV-mediated gene therapy for research and therapeutic purposes","volume":"1","author":"Samulski RJ Muzyczka","year":"2014","journal-title":"Annu Rev Virol"},{"issue":"17-18","key":"10.1016\/j.jaccao.2021.09.008_bib29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1089\/hum.2020.286","article-title":"Lack of toxicity in non-human primates receiving clinically relevant doses of an AAV9.U7snRNA vector designed to induce DMD exon 2 skipping","volume":"32","author":"Gushchina","year":"2021","journal-title":"Hum Gene Ther"},{"issue":"3685","key":"10.1016\/j.jaccao.2021.09.008_bib30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-associated defective virus particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/jvi.40.1.241-247.1981","article-title":"Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication","volume":"40","author":"Buller","year":"1981","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0042-6822(84)90272-1","article-title":"Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus","volume":"134","author":"Georg-Fries","year":"1984","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(85)90243-0","article-title":"Human cytomegalovirus completely helps adeno-associated virus replication","volume":"147","author":"McPherson","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.jaccao.2021.09.008_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","article-title":"Capsid modifications for targeting and improving the efficacy of AAV vectors","volume":"12","author":"Buning","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib35","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1038\/s41598-019-43737-y","article-title":"A\u00a0normothermic ex\u00a0vivo organ perfusion delivery method for cardiac transplantation gene therapy","volume":"9","author":"Bishawi","year":"2019","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1016\/j.jaccao.2021.09.008_bib36","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1089\/hum.2013.2515","article-title":"An emerging adeno-associated viral vector pipeline for cardiac gene therapy","volume":"24","author":"Asokan","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jaccao.2021.09.008_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fphys.2019.00168","article-title":"Adeno-associated virus mediated gene delivery: implications for scalable in\u00a0vitro and in\u00a0vivo cardiac optogenetic models","volume":"10","author":"Ambrosi","year":"2019","journal-title":"Frontiers in Physiology"},{"issue":"155","key":"10.1016\/j.jaccao.2021.09.008_bib38","first-page":"229","article-title":"Recent highlights and advances in cardiac gene therapy","volume":"28","author":"Oh","year":"2019","journal-title":"Discov Med"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/emmm.201202291","article-title":"Gene therapy enters the pharma market: the short story of a long journey","volume":"5","author":"B\u00fcning","year":"2013","journal-title":"EMBO Molecular Medicine"},{"issue":"11","key":"10.1016\/j.jaccao.2021.09.008_bib40","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","article-title":"Onasemnogene abeparvovec: first global approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.jaccao.2021.09.008_bib41","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41587-020-00773-8","article-title":"First systemic CRISPR agent in humans","volume":"38","year":"2020","journal-title":"Nature Biotechnology"},{"issue":"12","key":"10.1016\/j.jaccao.2021.09.008_bib42","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1161\/ATVBAHA.108.175620","article-title":"Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients","volume":"28","author":"Stroes","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.jaccao.2021.09.008_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11897-018-0410-z","article-title":"Gene therapy for heart failure: new perspectives","volume":"15","author":"Gabisonia","year":"2018","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"10.1016\/j.jaccao.2021.09.008_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial","volume":"15","author":"Jaski","year":"2009","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.jaccao.2021.09.008_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"issue":"7488","key":"10.1016\/j.jaccao.2021.09.008_bib46","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jaccao.2021.09.008_bib47","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gt.2011.143","article-title":"Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors","volume":"19","author":"Varadi","year":"2012","journal-title":"Gene Therapy"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1525-0016(03)00123-0","article-title":"In\u00a0vitro selection of viral vectors with modified tropism: the adeno-associated virus display","volume":"8","author":"Perabo","year":"2003","journal-title":"Molecular Therapy"},{"issue":"6","key":"10.1016\/j.jaccao.2021.09.008_bib49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/gt.2012.20","article-title":"Directed evolution of novel adeno-associated viruses for therapeutic gene delivery","volume":"19","author":"Bartel","year":"2012","journal-title":"Gene Therapy"},{"issue":"12","key":"10.1016\/j.jaccao.2021.09.008_bib50","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.00254-08","article-title":"In\u00a0vitro and\u00a0in\u00a0vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses","volume":"82","author":"Grimm","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaccao.2021.09.008_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jviromet.2017.09.008","article-title":"A\u00a0directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line","volume":"250","author":"Wooley","year":"2017","journal-title":"J\u00a0Virol Methods"},{"issue":"9-10","key":"10.1016\/j.jaccao.2021.09.008_bib52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/hum.2019.264","article-title":"High-throughput in\u00a0vitro, ex\u00a0vivo, and in\u00a0vivo screen of adeno-associated virus vectors based on physical and functional transduction","volume":"31","author":"Westhaus","year":"2020","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.jaccao.2021.09.008_bib53","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.omtm.2020.05.004","article-title":"Attenuation of heparan sulfate proteoglycan binding enhances in\u00a0vivo transduction of human primary hepatocytes with AAV2","volume":"17","author":"Cabanes-Creus","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.scr.2014.04.016","article-title":"SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development","volume":"13","author":"Skelton","year":"2014","journal-title":"Stem Cell Res"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12967-020-02605-4","article-title":"Comparative analysis of adeno-associated virus serotypes for gene transfer in organotypic heart slices","volume":"18","author":"Liu","year":"2020","journal-title":"J\u00a0Transl Med"},{"issue":"5","key":"10.1016\/j.jaccao.2021.09.008_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.jaccao.2021.09.008_bib57","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.109.868885","article-title":"Cardiomyocyte differentiation of human induced pluripotent stem cells","volume":"120","author":"Zwi","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib58","doi-asserted-by":"crossref","first-page":"15312","DOI":"10.1038\/s41598-018-33478-9","article-title":"A\u00a0comparative assessment of human and chimpanzee iPSC-derived cardiomyocytes with primary heart tissues","volume":"8","author":"Pavlovic","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jaccao.2021.09.008_bib59","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1203\/00006450-198105000-00003","article-title":"Myocardial consumption of oxygen and carbohydrates in newborn sheep","volume":"15","author":"Fisher","year":"1981","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40071-1","article-title":"Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity","volume":"9","author":"Rossi","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jaccao.2021.09.008_bib62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/CIRCRESAHA.114.300558","article-title":"Engineering adolescence","volume":"114","author":"Yang","year":"2014","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.jaccao.2021.09.008_bib63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.stemcr.2019.08.013","article-title":"Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells","volume":"13","author":"Yang","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jaccao.2021.09.008_bib64","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/ncomms4075","article-title":"Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing","volume":"5","author":"Adachi","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaccao.2021.09.008_bib65","doi-asserted-by":"crossref","first-page":"15041","DOI":"10.1038\/mtm.2015.41","article-title":"High-accuracy biodistribution analysis of adeno-associated virus variants by double barcode sequencing","volume":"2","author":"Marsic","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"10.1016\/j.jaccao.2021.09.008_bib66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.1016\/j.jaccao.2021.09.008_bib67","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3893","article-title":"Identification of liver-specific enhancer\u2013promoter activity in the 3\u2032 untranslated region of the wild-type AAV2 genome","volume":"49","author":"Logan","year":"2017","journal-title":"Nat Gen"},{"issue":"560","key":"10.1016\/j.jaccao.2021.09.008_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba3312","article-title":"Restoring the natural tropism of AAV2 vectors for human liver","volume":"12","author":"Cabanes-Creus","year":"2020","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.jaccao.2021.09.008_bib69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jgm.1576","article-title":"A\u00a0single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction","volume":"13","author":"Prasad","year":"2011","journal-title":"J\u00a0Gene Med"},{"issue":"3","key":"10.1016\/j.jaccao.2021.09.008_bib70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jgm.665","article-title":"Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus","volume":"7","author":"Kaspar","year":"2005","journal-title":"J\u00a0Gene Med"},{"issue":"5","key":"10.1016\/j.jaccao.2021.09.008_bib71","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/mt.2008.30","article-title":"Lentiviral vectors bearing the cardiac promoter of the Na+-Ca2+ exchanger report cardiogenic differentiation in stem cells","volume":"16","author":"Barth","year":"2008","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.jaccao.2021.09.008_bib72","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cardiores.2005.12.017","article-title":"Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors","volume":"70","author":"M\u00fcller","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"46","key":"10.1016\/j.jaccao.2021.09.008_bib73","doi-asserted-by":"crossref","first-page":"13144","DOI":"10.1073\/pnas.1616168113","article-title":"VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection","volume":"113","author":"R\u00e4s\u00e4nen","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jaccao.2021.09.008_bib74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11096-015-0070-y","article-title":"Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital","volume":"37","author":"Ayres","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"10.1016\/j.jaccao.2021.09.008_bib75","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIRCRESAHA.109.203596","article-title":"Human skeletal muscle drug transporters determine local exposure and toxicity of statins","volume":"106","author":"Knauer","year":"2010","journal-title":"Circ Res"},{"issue":"45","key":"10.1016\/j.jaccao.2021.09.008_bib76","doi-asserted-by":"crossref","first-page":"27807","DOI":"10.1016\/S0021-9258(18)46856-1","article-title":"The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates","volume":"269","author":"Leier","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"10.1016\/j.jaccao.2021.09.008_bib77","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tips.2006.06.008","article-title":"Transport of glutathione and glutathione conjugates by MRP1","volume":"27","author":"Cole","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jaccao.2021.09.008_bib78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fncir.2012.00047","article-title":"Novel recombinant adeno-associated viruses for Cre activated and inactivated transgene expression in neurons","volume":"6","author":"Saunders","year":"2012","journal-title":"Front Neural Circuits"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087321002490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087321002490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:54:25Z","timestamp":1762973665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087321002490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666087321002490"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2021.09.008","relation":{},"ISSN":["2666-0873"],"issn-type":[{"type":"print","value":"2666-0873"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Applications for Targeted Gene\u00a0Therapy to Protect Against Anthracycline Cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}